Company News for Nov 29, 2021

Zacks Equity Research Published on November 29, 2021

iSpecimen Inc.’s (ISPC - Free Report) shares jumped 71.7% after the company announced a contract to support new advanced research on COVID-19 seeking insights on its transmissibility, variants, outcomes, and testing validity among multiple population segments.
Shares of Aptevo Therapeutics Inc. (APVO - Free Report) rose 9.4% after the company announced a clinical update for its Phase 1b Expansion trial evaluating APVO436 in the treatment of AML.
Vir Biotechnology, Inc.’s (VIR - Free Report) shares surged 12.4% after the company signed contracts with the US government worth about $1 billion to secure the antibody-based COVID-19 treatment developed jointly with GlaxoSmithKline.
Shares of Cars.com Inc. (CARS - Free Report) jumped 21.1% after the company reported that it will replace DSP Group in the S&P SmallCap 600 before the opening of trading on Dec 2.

Zacks Names "Single Best Pick to Double"

From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.

It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.

This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.